FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1488741256> ?p ?o ?g. }

• W1488741256 endingPage "46" @default.
• W1488741256 startingPage "41" @default.
• W1488741256 abstract "Clioquinol was produced as a topical antiseptic and marketed as an oral intestinal amebicide in 1934, being used to treat a wide range of intestinal diseases. In the early 1970s, it was withdrawn from the market as an oral agent because of its association with subacute myelo-optic neuropathy (SMON), a syndrome that involves sensory and motor disturbances in the lower limbs and visual changes. The first methods for determining plasma and tissue clioquinol (5-chloro-7-iodo-8-quinolinol) levels were set up in the 1970s and involved HPLC separation with UV detection, these were followed by a more sensitive GC method with electron capture detection and a gaschromatographic-massspectrometric (GC-MS) method. Finally, an HPLC method using electrochemical detection has proved to be as highly sensitive and specific as the GC-MS. In rats, mice, rabbits, and hamsters, clioquinol is rapidily absorbed and undergoes first-pass metabolization to glucuronate and sulfate conjugates; the concentrations of the metabolites are higher than those of free clioquinol. Bioavailabilty versus intraperitoneal dosing is about 12%. Dogs and monkeys form fewer conjugates. In man, single-dose concentrations are dose related, and the drug's half-life is 11-14 h. There is no accumulation, and the drug is much less metabolized to conjugates. Clioquinol acts as a zinc and copper chelator. Metal chelation is a potential therapeutic strategy for Alzheimer's disease (AD) because zinc and copper are involved in the deposition and stabilization of amyloid plaques, and chelating agents can dissolve amyloid deposits in vitro and in vivo. In general, the ability of clioquinol to chelate and redistribute metals plays an important role in diseases characterised by Zn, Cu, Fe dyshomeostasis, such as AD and Parkinson's disease, as it reduces oxidation and the amyloid burden. Zinc chelators may also act as anticancer agents. Animal toxicity studies have revealed species-specific differences in neurotoxic responses that are related to the serum levels of clioquinol and metabolites. This is also true in humans, who form fewer conjugates. The results of studies of Alzheimer patients are conflicting and need further confirmation. The potential therapeutic role of the two main effects of MPACs (the regulation of the distribution of metals and antioxidants) has not yet been fully explored." @default.
• W1488741256 created "2016-06-24" @default.
• W1488741256 creator A5013556761 @default.
• W1488741256 creator A5091652199 @default.
• W1488741256 date "2010-12-27" @default.
• W1488741256 modified "2023-10-15" @default.
• W1488741256 title "Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders" @default.
• W1488741256 cites W1480108665 @default.
• W1488741256 cites W1491350259 @default.
• W1488741256 cites W1524626866 @default.
• W1488741256 cites W1591794773 @default.
• W1488741256 cites W1595180425 @default.
• W1488741256 cites W1607614294 @default.
• W1488741256 cites W1838272947 @default.
• W1488741256 cites W1971022916 @default.
• W1488741256 cites W1973123531 @default.
• W1488741256 cites W1982791049 @default.
• W1488741256 cites W1989403800 @default.
• W1488741256 cites W1992296450 @default.
• W1488741256 cites W1994340702 @default.
• W1488741256 cites W2001591118 @default.
• W1488741256 cites W2002330213 @default.
• W1488741256 cites W2002554762 @default.
• W1488741256 cites W2004545528 @default.
• W1488741256 cites W2008197060 @default.
• W1488741256 cites W2009252276 @default.
• W1488741256 cites W2017550829 @default.
• W1488741256 cites W2018362863 @default.
• W1488741256 cites W2021324819 @default.
• W1488741256 cites W2027944837 @default.
• W1488741256 cites W2030561694 @default.
• W1488741256 cites W2033770961 @default.
• W1488741256 cites W2051516838 @default.
• W1488741256 cites W2052815625 @default.
• W1488741256 cites W2054194868 @default.
• W1488741256 cites W2059963027 @default.
• W1488741256 cites W2066209708 @default.
• W1488741256 cites W2067279542 @default.
• W1488741256 cites W2070079507 @default.
• W1488741256 cites W2075040623 @default.
• W1488741256 cites W2079722596 @default.
• W1488741256 cites W2081099437 @default.
• W1488741256 cites W2083251455 @default.
• W1488741256 cites W2083500052 @default.
• W1488741256 cites W2112587738 @default.
• W1488741256 cites W2127960694 @default.
• W1488741256 cites W2130236043 @default.
• W1488741256 cites W2133324295 @default.
• W1488741256 cites W2139893103 @default.
• W1488741256 cites W2143643970 @default.
• W1488741256 cites W2150497621 @default.
• W1488741256 cites W2152058429 @default.
• W1488741256 cites W2314327059 @default.
• W1488741256 cites W2324557892 @default.
• W1488741256 doi "https://doi.org/10.1111/j.1755-5949.2010.00231.x" @default.
• W1488741256 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6493473" @default.
• W1488741256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21199452" @default.
• W1488741256 hasPublicationYear "2010" @default.
• W1488741256 type Work @default.
• W1488741256 sameAs 1488741256 @default.
• W1488741256 citedByCount "191" @default.
• W1488741256 countsByYear W14887412562012 @default.
• W1488741256 countsByYear W14887412562013 @default.
• W1488741256 countsByYear W14887412562014 @default.
• W1488741256 countsByYear W14887412562015 @default.
• W1488741256 countsByYear W14887412562016 @default.
• W1488741256 countsByYear W14887412562017 @default.
• W1488741256 countsByYear W14887412562018 @default.
• W1488741256 countsByYear W14887412562019 @default.
• W1488741256 countsByYear W14887412562020 @default.
• W1488741256 countsByYear W14887412562021 @default.
• W1488741256 countsByYear W14887412562022 @default.
• W1488741256 countsByYear W14887412562023 @default.
• W1488741256 crossrefType "journal-article" @default.
• W1488741256 hasAuthorship W1488741256A5013556761 @default.
• W1488741256 hasAuthorship W1488741256A5091652199 @default.
• W1488741256 hasBestOaLocation W14887412561 @default.
• W1488741256 hasConcept C150903083 @default.
• W1488741256 hasConcept C185592680 @default.
• W1488741256 hasConcept C207001950 @default.
• W1488741256 hasConcept C2776785578 @default.
• W1488741256 hasConcept C2777056448 @default.
• W1488741256 hasConcept C2780035454 @default.
• W1488741256 hasConcept C71924100 @default.
• W1488741256 hasConcept C86803240 @default.
• W1488741256 hasConcept C98274493 @default.
• W1488741256 hasConceptScore W1488741256C150903083 @default.
• W1488741256 hasConceptScore W1488741256C185592680 @default.
• W1488741256 hasConceptScore W1488741256C207001950 @default.
• W1488741256 hasConceptScore W1488741256C2776785578 @default.
• W1488741256 hasConceptScore W1488741256C2777056448 @default.
• W1488741256 hasConceptScore W1488741256C2780035454 @default.
• W1488741256 hasConceptScore W1488741256C71924100 @default.
• W1488741256 hasConceptScore W1488741256C86803240 @default.
• W1488741256 hasConceptScore W1488741256C98274493 @default.
• W1488741256 hasIssue "1" @default.
• W1488741256 hasLocation W14887412561 @default.
• W1488741256 hasLocation W14887412562 @default.

• next